September 21, 2017 Acad, Gov/Utilities Clinical Research/Diagn. Lab Top-10

State Key Laboratory of Biochemical Engineering and PerkinElmer Open Joint Translational Medical Engineering Demonstration Laboratory in Beijing

New Facility Helps Scientists Advance Translational Medical Research WHAT:              PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the opening of the Translational Medical Engineering Demonstration Laboratory at a ceremony on September 19.  Co-founded with the State Key Laboratory of Biochemical Engineering, this facility will serve as a center for... Read more

July 27, 2017 Clinical Research/Diagn. M&A, Partnerships

Fluidigm and Ascendas Genomics Announce Strategic Partnership to Develop Microfluidic Molecular Diagnostics in China

SOUTH SAN FRANCISCO, Calif. and ZHONGSHAN, China, July 27, 2017 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM) and Ascendas Genomics today announced a strategic partnership to develop molecular diagnostics in China. Under the terms of the partnership, Ascendas Genomics will develop and commercialize molecular diagnostic systems and assays in China using microfluidic technologies included in the Fluidigm® Biomark™ HD and Juno™ systems. Fluidigm’s microfluidic technology enables... Read more

June 29, 2017 Chromatography Clinical Research/Diagn. Mass Spectrometry

The New SCIEX Clinical AB SCIEX TRIPLE QUAD™ 4500MD LC-MS/MS System Obtains CFDA Approval as Medical Device for in vitro Diagnostic Use

The AB SCIEX TRIPLE QUAD™ 4500MD LC-MS/MS system has been approved by the China Food and Drug Administration (CFDA) and meets the market access requirements for medical device products. 1 June 29, 2017 Shanghai, China — SCIEX Diagnostics, the in vitro diagnostics division of SCIEX, a global leader in mass spectrometry in the life sciences industry, announced today that... Read more

June 21, 2017 Life Science Tools

Beijing 4P Health Research Institute initiates China’s “100K Wellness Pioneer Project” using UniteGen and Sapientia™ integrated platform

Commercial agreement with Congenica supports UniteGen’s goal of achieving the world’s largest human genome database Cambridge, UK – 21st June –  Congenica’s Sapientia™ clinical genome analysis software platform will be used by China-based UniteGen to carry out whole genome sequencing (WGS) processing and analysis as part of China’s “100K Wellness Pioneer Project”, hosted by Beijing... Read more

May 2, 2017 Life Science Tools M&A, Partnerships

QIAGEN partners with Maccura to localize and commercialize GeneReader NGS System in China

Partnership with a leading Chinese IVD company with goal to accelerate penetration of the world’s first complete Sample to Insight NGS solution in rapidly growing Chinese market Hilden, Germany, and Chengdu, China, May 2, 2017 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the formation of a joint venture with Maccura Biotechnology... Read more

February 13, 2017 Molecular Spectroscopy

Smiths Detection’s IONSCAN 600 receives CAAC approval

13 Feb 2017   Bringing the next generation explosives and narcotics trace detector to passenger and baggage screening at Chinese airports SINGAPORE, 13 February 2017 – Smiths Detection today announces that its next generation portable, explosives and narcotics trace detector, the IONSCAN 600, has been approved for explosives trace detection as part of the passenger and... Read more

May 9, 2016 Bio/Pharma/CRO

JHL Biotech Opens Innovative Biosimilars Manufacturing Facility in China

CHALFONT ST. GILES, UK and WUHAN, CHINA – 10 May 2016 –JHL Biotech (JHL), a biopharmaceutical company, opened the world’s first KUBio™ biopharmaceutical manufacturing facility with single-use bioprocessing technology at a ribbon-cutting ceremony in Wuhan, China today. JHL will use the KUBio manufacturing solution delivered by GE Healthcare to manufacture biosimilars(1) and monoclonal antibodies (mAbs)... Read more

February 29, 2016 Bio/Pharma/CRO M&A, Partnerships

JHL Biotech Announces Mechanical Completion of its Wuhan Biopharmaceutical Manufacturing Facility

WUHAN, China and AMERSHAM, England, Feb. 25, 2016 /PRNewswire/ — JHL Biotech (TPEx: 6540) and GE Healthcare’s Life Sciences business (NYSE: GE) are proud to announce mechanical completion of JHL Biotech’s JHL-1 biopharmaceutical manufacturing facility in the Biolake area of Wuhan, China. The campus was built to be compliant with the highest international standards, and after site validation is completed in June... Read more